Biolargo (NMED) Q1 2026 Earnings

5MarConfirmed
Q1 2025
Q3 2025
Q4 2025
Q1 2026
-0.02
-0.01
-0.01
0

Details

Expected EPS
-0.01
Actual EPS
-0.012
Surprise EPS
-0
Surprise Percent
+20%

Description

Biolargo (NMED) has reported earnings of -0.012 per share for Q1 2026.

0 Comments

Share your thoughts